Tag: Cycloserine

Up to 30% of patients experience side effects when taking cycloserine, a second-line antibiotic for tuberculosis [1.2.2]. Understanding 'What are the contraindications for cycloserine?' is crucial for patient safety and effective treatment outcomes.

Globally, an estimated 400,000 people developed multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) in 2023. For these patients, understanding second-line treatments is critical. So, **what kind of drug is cycloserine?** It's a crucial broad-spectrum antibiotic used to fight this challenging disease.

Up to 30% of patients experience side effects when taking cycloserine [1.4.4]. Knowing **which condition is adverse to cycloserine** is critical for patient safety, especially for those with pre-existing neurological, psychiatric, or renal issues [1.2.3, 1.3.4].